Estalis 50/250, transdermale Pflaster

7680547040894 CH-54704 Pflaster
Estalis 50/250, transdermale Pflaster
Estalis 50/250, transdermale Pflaster
Estalis 50/250, transdermale Pflaster
1 / 3
google

Article details

Package size
8
Selling units
8
Measure
Pflaster
Galenic form
Pflaster
Galenic group
Pflaster/Transdermale Systeme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/10/2025
Patient information leaflet
Français
21/10/2025
Patient information leaflet
Italien
21/10/2025
Summary of Product Characteristics
Allemand
21/10/2025
Summary of Product Characteristics
Français
21/10/2025
Summary of Product Characteristics
Italien
21/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.496 MG Substance Wirkstoff (Principe actif)
(N/A)
0.512 MG Substance WIZUS
(N/A)
4.8 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
54704
Drug name
Estalis, transdermale Pflaster
Galenic form
TRAP
ATC Code
G03FA01
Authorization status
Z
Dispensing category
B
First authorization
17/08/1999
Authorization expiration date
31/12/9999
IT Number
07.08.6.
Domain
Human medicine
Field of application
Oestrogen-Gestagen-Substitutionstherapie nach der Menopause

Package details

Description (FR)
ESTALIS patch mat 50/250 8 pce
Description (DE)
ESTALIS Matrixpfl 50/250 8 Stk
Market launch
17/08/1999
Narcotic (BTM)
No

Other package sizes (3)

ESTALIS patch mat 50/140 8 pce
8 PFLA
GTIN: 7680547040627
View
ESTALIS patch mat 50/140 24 pce
24 PFLA
GTIN: 7680547040702
View
ESTALIS patch mat 50/250 24 pce
24 PFLA
GTIN: 7680547040979
View